FCHSD2-FAM168A Fusion FISH Probe
The FCHSD2-FAM168A Fusion FISH Probe is used to confirm a fusion of the FCHSD2 and FAM168A genes. The fusion of the FCHSD2 and FAM168A genes has been associated with Uterine Corpus Endometrial Carcinoma, Uterine Corpus Endometrial Carcinoma, and Cervical Squamous Cell Carcinoma And Endocervical Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| FCHSD2-FAM168A-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-RERE | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-REOR | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-REGO | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-REGR | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-OROR | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-GORE | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-GROR | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-FAM168A-20-AQAQ | 20 (40 μL) | 200 μL |
|
FCHSD2 Gene Summary
The FCH And Double SH3 Domains 2 (FCHSD2) gene is located on chr11 :72547789-72853143 at 11q13.4.
Gene Name: FCH And Double SH3 Domains 2
Chromosome: CHR11: 72547789 -72853143
Locus: 11q13.4
FAM168A Gene Summary
The Family With Sequence Similarity 168 Member A (FAM168A) gene is located on chr11 :73117027-73309228 at 11q13.4.
Gene Name: Family With Sequence Similarity 168 Member A
Chromosome: CHR11: 73117027 -73309228
Locus: 11q13.4
Gene Diseases
The FCHSD2 FAM168A Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Uterine Corpus Endometrial Carcinoma |
| Uterine Corpus Endometrial Carcinoma |
| Cervical Squamous Cell Carcinoma And Endocervical Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|